In a landmark move set to reshape the landscape of global wellness and regenerative medicine, European Wellness Biomedic...
La Trobe University, Australia and India’s Biotechnology Industry Research Assistance Council (BIRAC) have signed ...
The Premier of Victoria, Jacinta Allan recently opened the University of Melbourne’s first Melbourne Global Centre...
The Cumming Global Centre for Pandemic Therapeutics in Melbourne, Australia and the University of Bonn in Germany, have ...
Looking ahead, BIOCHINA 2025 has officially announced its next conference, set for March 13-15, 2025. The 10th edition o...
A novel approach for analysing single-cell RNA sequencing (scRNA-seq) data has been unveiled by researchers at the Natio...
South Korea-based GC Cell, a leading innovator in cell therapy, has announced the execution of a landmark 'Technology Tr...
A grand opening ceremony for the HKU Techno-Entrepreneurship Academy (TEA) in Shenzhen Qianhai was held recently. This ...
The Thailand Center of Excellence for Life Sciences (TCELS) proudly presents Bio Asia Pacific 2024, under the theme &ldq...
The University of Sydney's $100,000 commitment towards research with the Public Health Foundation of India will allow ...
Australia-based biotechnology company CSL Limited has entered into an agreement with Chengdu Rongsheng Pharmaceuti...
US-based HFS Research has released a report in collaboration with Indegene, elaborating how Generative AI (Gen...
The Centre for Chinese Herbal Medicine Drug Development (CDD) at Hong Kong Baptist University (HKBU) has ...
Rigaku Corporation, a Rigaku Holdings Group company and global partner for X-ray analysis from Lab to Fab in Japan, has ...
Australia's University of Sydney researchers will lead two new national medical research centres focused on the elimin...
The Secretary for Health, Professor Lo Chung-mau, met the Administrator of the National Disease Control and Prevention A...
The Albanese Labor Government is equipping Australian researchers to find new treatments and breakthrough cures with the...
Can you provide insight into the selection process for ventures at Proto Axiom? What key factors determine which ideas o...
Japan’s biotech sector is a landscape rife with opportunity, yet also a complex market that requires a deep unders...
Japan has a robust drug discovery capability, having developed an interleukin-6 inhibitor, a programmed cell death prote...
Japan's biotech ecosystem is at a pivotal moment, characterised by both challenges and opportunities. Despite a rich his...
On July 30 2024, Japanese Prime Minister Fumio Kishida unveiled a roadmap to establish Japan as a ‘drug discovery ...
The Albanese Labor Government in Australia is investing $60 million to bring together some of Australia’s best hea...
Lotte Holdings Co. has announced the establishment of a new Healthcare and Biopharmaceutical Corporate Venture Capital (...
Coverage By Hithaishi Bhaskar The BIO Asia–Taiwan 2024 Exhibition was held at the Taipei Nangang E...
